The report provides industry landscape, competitive landscape and industry trends data on the cardiovascular monitoring and diagnostic devices industry . The report provides comprehensive data on the major industry developments affecting the industry, and key analytical content on the industry dynamics. The report also reviews the competitive landscape and technology offerings.


Scope of the Research

- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Key sectors covered include ECG Monitoring Equipment, ECG Stress Testing Systems, Holter and Event Monitoring Systems and Cardiopulmonary Stress Testing Systems.
- Annualized industry revenues data from 2003 to 2010, projection forward for 7 years to 2017. Firms shares data for 2010.
- Qualitative analysis of key industry trends, industry drivers, and restraints by each category within cardiovascular monitoring and diagnostic devices industry .
- The report also covers data on the leading industry players, the competitive landscape, and the leading new product development and technologies.
- Key Companies covered include GE Healthcare, Philips Healthcare, Fukuda Denshi, Nihon Kohden and Cardiac Science Corporation.

Why Should You Get This Report?

- Develop business strategies by understanding the trends and developments that are driving the cardiovascular monitoring and diagnostic devices industry globally.
- Design and develop your product development, industry ing and sales strategies.
- Develop successful market-entry strategies .
- Identify key players best positioned to take advantage of the emerging industry opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What’s the next big thing in the cardiovascular monitoring and diagnostic devices industry landscape? – Identify, understand and decide.
- Make more informed business decisions from the insightful and in-depth analysis of the global cardiovascular monitoring and diagnostic devices industry and the factors shaping it.

Table Of Contents

1 Table of contents

I Table of contents 3
I. 1 List of Data tables 6
I. 2 List of Charts 8

II Introduction 10
II. 1 GlobalData Report Guidance 10

III Cardiovascular Monitoring and Diagnostic Devices Overview 11
III. 1 ECG Monitoring Equipment 11
III. 2 ECG Stress Testing Systems 11
III. 3 Holter Monitoring Systems 12
III. 4 Event Monitoring Systems 12
III. 5 Cardiopulmonary Stress Testing Systems 13
III. 6 ECG Data Management Systems 13
4 World Cardiovascular Monitoring and Diagnostic Devices: March ket Characterization 14
IV. 1 Cardiovascular Monitoring and Diagnostic Devices March ket, Global, Sales (USD Million), Historical data, 2003?2010 14
IV. 2 Cardiovascular Monitoring and Diagnostic Devices March ket, Global, Sales (USD Million), Forecasted data, 2010?2017 15
IV. 3 Cardiovascular Monitoring and Diagnostic Devices, Key March ket Trends 16
IV. 3.1 Mobile Cardiac Outpatient Telemetry is Expected to Find Increased Adoption in the Future 16
IV. 3.2 Wireless ECG with Bluetooth Technology is the Latest Technological Trend in the ECG Monitoring Devices March ket 17
IV. 3.3 Growth of Personal Computer (PC) based Systems Improves March ket Penetration 18
IV. 3.4 Portable ECG Monitoring Systems are Allowing for Home Testing, Leading to a Greater Number of Tests and Increased March ket Penetration 18
IV. 3.5 Advances in ECG Waveform Analysis and Algorithm Technology are Expected to Enhance the Potential Applications of ECG Monitoring 19
IV. 3.6 Dry Electrode Technology for ECG Monitoring is Set to Witness Increased Adoption in the Near Future 20
IV. 4 Cardiovascular Monitoring and Diagnostic Devices, March ket Dynamics 20
IV. 4.1 March ket Drivers 21
IV. 4.2 March ket Restraints 25
5 World Cardiovascular Monitoring and Diagnostic Devices March ket: Analysis by Sector 27
V. 1 ECG Monitoring Equipment: March ket Characterization 27
V. 1.1 ECG Monitoring Equipment, Global, Sales (USD Million), Historical data, 2003?2010 27
V. 1.2 ECG Monitoring Equipment, Global, Sales (USD Million), Forecasted data, 2010?2017 28
V. 1.3 ECG Monitoring Equipment, March ket Driver: Growing Use of ECG Supplies in Alternate Care Settings to Drive March ket Growth 29
V. 1.4 ECG Monitoring Equipment, March ket Restraint: Limitation of Use and False Positive Results are Key Factors Hampering the Adoption of ECG Monitoring 29
V. 2 ECG Stress Testing Systems: March ket Charaterization 30
V. 2.1 ECG Stress Testing Systems March ket, Global, Sales (USD Million), Historical data, 2003?2010 30
V. 2.2 ECG Stress Testing Systems March ket, Global, Sales (USD Million), Forecasted data, 2010?2017 31
V. 2.3 ECG Stress Testing Systems, March ket Driver: Increasing Incidence of Coronary Heart Disease is Expected to August ment the March ket Growth 32
V. 2.4 ECG Stress Testing Systems, March ket Restraint: Emergence of Cardiopulmonary Stress Testing Systems will Negatively Impact the March ket Growth 32
V. 3 Holter and Event Monitoring Systems: March ket Charaterization 33
V. 3.1 Holter Monitoring Systems March ket, Global, Sales (USD Million), Historical data, 2003?2010 33
V. 3.2 Holter Monitoring Systems March ket, Global, Sales (USD Million), Forecasted data, 2010?2017 34
V. 3.3 Event Monitoring Systems, Global, Sales (USD Million), Historical data, 2003?2010 35
V. 3.4 Event Monitoring Systems, Global, Sales (USD Million), Forecasted data, 2010?2017 36
V. 3.5 Holter and Event Monitoring Systems, March ket Driver: Continuous Cardiac Monitoring Fosters the Demand for Ambulatory Monitoring Devices such as Holter and Event Monitoring Systems 37
V. 3.6 Holter and Event Monitoring Systems, March ket Restraint: Limitations of Ambulatory ECG Monitoring for Assessment of Myocardial Ischemia Expected to Limit its Use 37
V. 4 Cardiopulmonary Stress Testing Systems: March ket Charaterization 38
V. 4.1 Cardiopulmonary Stress Testing Systems, Global, Sales (USD Million), Historical data, 2003?2010 38
V. 4.2 Cardiopulmonary Stress Testing Systems, Global, Sales (USD Million), Forecasted data, 2010?2017 39
V. 4.3 Cardiopulmonary Stress Testing Systems, March ket Drivers 40
V. 4.4 Cardiopulmonary Stress Testing Systems, March ket Restraint: Lack of Affordability in the Developing World will Restrain the Growth of the CPST March ket 41
V. 5 ECG Data Management Systems: March ket Charaterization 42
V. 5.1 ECG Data Management Systems, Global, Sales (USD Million), Historical data, 2003?2010 42
V. 5.2 ECG Data Management Systems, Global, Sales (USD Million), Forecasted data, 2010?2017 43
V. 5.3 ECG Data Management Systems, March ket Driver: Potential Cost Benefit will August ment the March ket Growth 44
V. 5.4 ECG Data Management Systems, March ket Restraint: High Installation and Switching Cost is Expected to Hinder the March ket Growth 44

VI Cardiovascular Monitoring and Diagnostic Devices March ket, by Country, Sales (USD Million), 2003-2017 45
VI. 1 Cardiovascular Monitoring and Diagnostic Devices March ket, the US, Sales (USD Million), Historical data, 2003?2010 45
VI. 2 Cardiovascular Monitoring and Diagnostic Devices March ket, the US, Sales (USD Million), Forecasted data, 2010?2017 46
VI. 3 Cardiovascular Monitoring and Diagnostic Devices March ket, Canada, Sales (USD Million), Historical data, 2003?2010 47
VI. 4 Cardiovascular Monitoring and Diagnostic Devices March ket, Canada, Sales (USD Million), Forecasted data, 2010?2017 48
VI. 5 Cardiovascular Monitoring and Diagnostic Devices March ket, the UK, Sales (USD Million), Historical data, 2003?2010 49
VI. 6 Cardiovascular Monitoring and Diagnostic Devices March ket, the UK, Sales (USD Million), Forecasted data, 2010?2017 50
VI. 7 Cardiovascular Monitoring and Diagnostic Devices March ket, Germany, Sales (USD Million), Historical data, 2003?2010 51
VI. 8 Cardiovascular Monitoring and Diagnostic Devices March ket, Germany, Sales (USD Million), Forecasted data, 2010?2017 52
VI. 9 Cardiovascular Monitoring and Diagnostic Devices March ket, France, Sales (USD Million), Historical data, 2003?2010 53
VI. 10 Cardiovascular Monitoring and Diagnostic Devices March ket, France, Sales (USD Million), Forecasted data, 2010?2017 54
VI. 11 Cardiovascular Monitoring and Diagnostic Devices March ket, Italy, Sales (USD Million), Historical data, 2003?2010 55
VI. 12 Cardiovascular Monitoring and Diagnostic Devices March ket, Italy, Sales (USD Million), Forecasted data, 2010?2017 56
VI. 13 Cardiovascular Monitoring and Diagnostic Devices March ket, Spain, Sales (USD Million), Historical data, 2003?2010 57
VI. 14 Cardiovascular Monitoring and Diagnostic Devices March ket, Spain, Sales (USD Million), Forecasted data, 2010?2017 58
VI. 15 Cardiovascular Monitoring and Diagnostic Devices March ket, Japan, Sales (USD Million), Historical data, 2003?2010 59
VI. 16 Cardiovascular Monitoring and Diagnostic Devices March ket, Japan, Sales (USD Million), Forecasted data, 2010?2017 60
VI. 17 Cardiovascular Monitoring and Diagnostic Devices March ket, China, Sales (USD Million), Historical data, 2003?2010 61
VI. 18 Cardiovascular Monitoring and Diagnostic Devices March ket, China, Sales (USD Million), Forecasted data, 2010?2017 62
VI. 19 Cardiovascular Monitoring and Diagnostic Devices March ket, India, Sales (USD Million), Historical data, 2003?2010 63
VI. 20 Cardiovascular Monitoring and Diagnostic Devices March ket, India, Sales (USD Million), Forecasted data, 2010?2017 64
VI. 21 Cardiovascular Monitoring and Diagnostic Devices March ket, Australia, Sales (USD Million), Historical data, 2003?2010 65
VI. 22 Cardiovascular Monitoring and Diagnostic Devices March ket, Australia, Sales (USD Million), Forecasted data, 2010?2017 66
VI. 23 Cardiovascular Monitoring and Diagnostic Devices March ket, Brazil, Sales (USD Million), Historical data, 2003?2010 67
VI. 24 Cardiovascular Monitoring and Diagnostic Devices March ket, Brazil, Sales (USD Million), Forecasted data, 2010?2017 68
7 World Cardiovascular Monitoring and Diagnostic Devices March ket: Competitive Assessment 69
VII. 1 Cardiovascular Monitoring and Diagnostic Devices March ket, Global, Key Market Shares s (%), 2009 69
VII. 2 Cardiovascular Monitoring and Diagnostic Devices, March ket Opportunities (SWOT Analysis) and Risk Evaluation 70
VII. 2.1 March ket Opportunities (SWOT Analysis) 70
VII. 2.2 Risk Evaluation 71
VII. 3 Cardiovascular Monitoring and Diagnostic Devices March ket, Key March ket Participants 71
VII. 3.1 GE Healthcare 71
VII. 3.2 Philips Healthcare 73
VII. 3.3 Fukuda Denshi 75
VII. 3.4 Nihon Kohden 76
VII. 3.5 Cardiac Science Corporation 77
VII. 4 Key Cardiovascular Monitoring and Diagnostic Devices in the March ket 79
VII. 4.1 MAC 1600 Electrocardiograph, GE Healthcare 79
VII. 4.2 Seer Holter Recorders, GE Healthcare 80
VII. 4.3 TraceMasterVue ECG Management System, Philips Healthcare 80
VII. 4.4 Cardiofax ECG-9620, Nihon Kohden 81
VII. 4.5 Pyramis ECG Data Management, Cardiac Science Corporation 81
VII. 4.6 Burdick Vision 5L / 5LR Digital Holter Recorders, Cardiac Science Corporation 82

VIII Cardiovascular Monitoring and Diagnostic Devices, Pipeline Assessment 83
VIII. 1 Cardiovascular Monitoring and Diagnostic Devices under Clinical Development 83
VIII. 2 Profiles of Promising Cardiovascular Monitoring and Diagnostic Device Products under Clinical Development 86
VIII. 2.1 AngelMed Guardian System 86
VIII. 2.2 CardioBip 88
VIII. 2.3 Cardio3KG 88
VIII. 2.4 Electrocardiographic Mapping System 89
VIII. 2.5 Fidelity 350 Holter Monitor 91
VIII. 2.6 SupraQ 91
VIII. 2.7 Heart Vital Signs 93
VIII. 2.8 VectraplexECG Monitor 93
9 World Cardiovascular Monitoring and Diagnostic Devices March ket - Merger and Acquisition Landscape 94
IX. 1.1 World Cardiovascular Monitoring and Diagnostic Devices March ket - Deals Overview 94
IX. 2 Key Deals in the Cardiovascular Monitoring and Diagnostic Devices March ket 96
IX. 2.1 CardioNet Completes Acquisition of Biotel 96
IX. 2.2 Opto Circuits Completes Acquisition of Cardiac Science 96
IX. 2.3 SonoSite Completes Acquisition of CardioDynamics International 96
IX. 2.4 St. Jude Medical Invests US$ 60m in CardioMEMS 97
IX. 2.5 Cardionet Takes Over PDSHeart 97

X Appendix 98
X. 1 Definitions 99
X. 1.1 Cardiovascular Monitoring and Diagnostic Devices 99
X. 2 Acronyms 100
X. 3 Sources 101
X. 3.1 Firms Websites, Financial Reports, Investor Presentations and Investor Calls 101
X. 3.2 Online Journals, Websites and Trade Magazines 101
X. 3.3 Associations and Organizations 101
X. 4 Research Methodology 101
X. 5 Secondary Research 101
X. 6 Primary Research 102
X. 7 Models 102
X. 8 Forecasted data s 102
X. 9 Expert Panels 103
X. 10 GlobalData Consulting 103
X. 11 Contact Us 103
X. 12 Disclaimer 103

1.1 List of Data tables

Data table 1: Cardiovascular Monitoring and Diagnostic Devices March ket, Global, Sales (USD Million), 2003?2010 14
Data table 2: Cardiovascular Monitoring and Diagnostic Devices March ket, Global, Sales (USD Million), 2010?2017 15
Data table 3: ECG Monitoring Equipment March ket, Sales (USD Million), 2003?2010 27
Data table 4: ECG Monitoring Equipment, Global, Sales (USD Million), 2010?2017 28
Data table 5: ECG Stress Testing Systems March ket, Global, Sales (USD Million), 2003?2010 30
Data table 6: ECG Stress Testing Systems March ket, Sales (USD Million), 2010?2017 31
Data table 7: Holter Monitoring Systems March ket, Sales (USD Million), 2003?2010 33
Data table 8: Holter Monitoring Systems March ket, Sales (USD Million), 2010?2017 34
Data table 9: Event Monitoring Systems March ket, Sales (USD Million), 2003?2010 35
Data table 10: Event Monitoring Systems March ket, Sales (USD Million), 2010?2017 36
Data table 11: Cardiopulmonary Stress Testing Systems March ket, Sales (USD Million), 2003?2010 38
Data table 12: Cardiopulmonary Stress Testing Systems March ket, Sales (USD Million), 2010?2017 39
Data table 13: ECG Data Management Systems March ket, Sales (USD Million), 2003?2010 42
Data table 14: Cardiopulmonary Stress Testing Systems March ket, Sales (USD Million), 2010?2017 43
Data table 15: Cardiovascular Monitoring and Diagnostic Devices March ket, US, Sales (USD Million), 2003?2010 45
Data table 16: Cardiovascular Monitoring and Diagnostic Devices March ket, the US, Sales (USD Million), 2010?2017 46
Data table 17: Cardiovascular Monitoring and Diagnostic Devices March ket, Canada, Sales (USD Million), 2003?2010 47
Data table 18: Cardiovascular Monitoring and Diagnostic Devices March ket, Canada, Sales (USD Million), 2010?2017 48
Data table 19: Cardiovascular Monitoring and Diagnostic Devices March ket, the UK, Sales (USD Million), 2003?2010 49
Data table 20: Cardiovascular Monitoring and Diagnostic Devices March ket, the UK, Sales (USD Million), 2010?2017 50
Data table 21: Cardiovascular Monitoring and Diagnostic Devices March ket, Germany, Sales (USD Million), 2003?2010 51
Data table 22: Cardiovascular Monitoring and Diagnostic Devices March ket, Germany, Sales (USD Million), 2010?2017 52
Data table 23: Cardiovascular Monitoring and Diagnostic Devices March ket, France, Sales (USD Million), 2003?2010 53
Data table 24: Cardiovascular Monitoring and Diagnostic Devices March ket, France, Sales (USD Million), 2010?2017 54
Data table 25: Cardiovascular Monitoring and Diagnostic Devices March ket, Italy, Sales (USD Million), 2003?2010 55
Data table 26: Cardiovascular Monitoring and Diagnostic Devices March ket, Italy, Sales (USD Million), 2010?2017 56
Data table 27: Cardiovascular Monitoring and Diagnostic Devices March ket, Spain, Sales (USD Million), 2003?2010 57
Data table 28: Cardiovascular Monitoring and Diagnostic Devices March ket, Spain, Sales (USD Million), 2010?2017 58
Data table 29: Cardiovascular Monitoring and Diagnostic Devices March ket, Japan, Sales (USD Million), 2003?2010 59
Data table 30: Cardiovascular Monitoring and Diagnostic Devices March ket, Japan, Sales (USD Million), 2010?2017 60
Data table 31: Cardiovascular Monitoring and Diagnostic Devices March ket, China, Sales (USD Million), 2003?2010 61
Data table 32: Cardiovascular Monitoring and Diagnostic Devices March ket, China, Sales (USD Million), 2010?2017 62
Data table 33: Cardiovascular Monitoring and Diagnostic Devices March ket, India, Sales (USD Million), 2003?2010 63
Data table 34: Cardiovascular Monitoring and Diagnostic Devices March ket, India, Sales (USD Million), 2010?2017 64
Data table 35: Cardiovascular Monitoring and Diagnostic Devices March ket, Australia, Sales (USD Million), 2003?2010 65
Data table 36: Cardiovascular Monitoring and Diagnostic Devices March ket, Australia, Sales (USD Million), 2010?2017 66
Data table 37: Cardiovascular Monitoring and Diagnostic Devices March ket, Brazil, Sales (USD Million), 2003?2010 67
Data table 38: Cardiovascular Monitoring and Diagnostic Devices March ket, Brazil, Sales (USD Million), 2010?2017 68
Data table 39: Cardiovascular Monitoring and Diagnostic Devices March ket, Global, Sales s (USD Million), 2010 69
Data table 40: GE Healthcare, Key March keted Products, 2010 72
Data table 41: Philips Healthcare, Key March keted Products, 2010 73
Data table 42: Fukuda Denshi, Key March keted Products, 2010 75
Data table 43: Nihon Kohden, Key March keted Products, 2010 76
Data table 44: Cardiac Science Corporation, Key March keted Products, 2010 77
Data table 45: MAC 1600 electrocardiograph, Features and Benefits 79
Data table 46: Seer Holter Recorders, Features and Benefits 80
Data table 47: TraceMasterVue ECG Management System, Features and Benefits 80
Data table 48: Cardiofax ECG-9620, Features and Benefits 81
Data table 49: Pyramis ECG Data Management, Features and Benefits 81
Data table 50: Burdick Vision 5L / 5LR Digital Holter Recorders, Features and Benefits 82
Data table 51: List of Cardiovascular Monitoring and Diagnostic Device Products under Clinical Development, 2010 83
Data table 52: AngelMed Guardian System, Product Status, 2010 86
Data table 53: AngelMed Guardian System - DETECT - Feasibility Study of an Implantable Device to Monitor ST-Segment Shifts and Alert Patients to Cardiac Ischemia 87
Data table 54: CardioBip, Product Status, 2010 88
Data table 55: Cardio3KG, Product Status, 2010 88
Data table 56: Cardio3KG - A Study on VisualECG for Acute Coronary Syndrome 89
Data table 57: Electrocardiographic Mapping System, Product Status, 2010 90
Data table 58: Electrocardiographic Mapping System - Electrocardiographic Imaging of Cardiac Resynchronization Therapy in Heart Failure: Observation of Variable Electrophysiologic Responses 90
Data table 59: Fidelity 350 Holter Monitor, Product Status, 2010 91
Data table 60: SupraQ, Product Status, 2010 91
Data table 61: SupraQ - SupraQ Monitor Trial to Look At Haemodynamic Stability During Epidural Anaesthesia 92
Data table 62: Heart Vital Signs, 2010 93
Data table 63: VectraplexECG Monitor, Product Status, 2010 93
Data table 64: Cardiovascular Monitoring and Diagnostic Devices March ket, Global, Mergers and Acquisitions, 2007-2010 95

1.2 List of Charts

Chart 1: Cardiovascular Monitoring and Diagnostic Devices, March ket Segmentation 10
Chart 2: Cardiovascular Monitoring and Diagnostic Devices March ket, Global, Sales (USD Million), 2003?2010 13
Chart 3: Cardiovascular Monitoring and Diagnostic Devices March ket, Global, Sales (USD Million), 2010?2017 14
Chart 4: Cardiovascular Monitoring and Diagnostic Devices, Key March ket Trends 15
Chart 5: Cardiovascular Monitoring and Diagnostic Devices, March ket Drivers and Restraints 19
Chart 6: Emerging Economies, Gross Domestic Product Forecasted data, Healthcare Expenditure and Drivers 21
Chart 7: ECG Monitoring Equipment March ket, Sales (USD Million), 2003?2010 26
Chart 8: ECG Monitoring Equipment, Global, Sales (USD Million), 2010?2017 27
Chart 9: ECG Stress Testing Systems March ket, Global, Sales (USD Million), 2003?2010 29
Chart 10: ECG Stress Testing Systems March ket, Sales (USD Million), 2010?2017 30
Chart 11: Holter Monitoring Systems March ket, Sales (USD Million), 2003?2010 32
Chart 12: Holter Monitoring Systems March ket, Sales (USD Million), 2010?2017 33
Chart 13: Event Monitoring Systems March ket, Sales (USD Million), 2003?2010 34
Chart 14: Event Monitoring Systems March ket, Sales (USD Million), 2010?2017 35
Chart 15: Cardiopulmonary Stress Testing Systems March ket, Sales (USD Million), 2003?2010 37
Chart 16: Cardiopulmonary Stress Testing Systems March ket, Sales (USD Million), 2010?2017 38
Chart 17: ECG Data Management Systems March ket, Sales (USD Million), 2003?2010 41
Chart 18: ECG Data Management Systems March ket, Sales (USD Million), 2010?2017 42
Chart 19: Cardiovascular Monitoring and Diagnostic Devices March ket, the US, Sales (USD Million), 2003?2010 44
Chart 20: Cardiovascular Monitoring and Diagnostic Devices March ket, the US, Sales (USD Million), 2010?2017 45
Chart 21: Cardiovascular Monitoring and Diagnostic Devices March ket, Canada, Sales (USD Million), 2003?2010 46
Chart 22: Cardiovascular Monitoring and Diagnostic Devices March ket, Canada, Sales (USD Million), 2010?2017 47
Chart 23: Cardiovascular Monitoring and Diagnostic Devices March ket, the UK, Sales (USD Million), 2003?2010 48
Chart 24: Cardiovascular Monitoring and Diagnostic Devices March ket, the UK, Sales (USD Million), 2010?2017 49
Chart 25: Cardiovascular Monitoring and Diagnostic Devices March ket, Germany, Sales (USD Million), 2003?2010 50
Chart 26: Cardiovascular Monitoring and Diagnostic Devices March ket, Germany, Sales (USD Million), 2010?2017 51
Chart 27: Cardiovascular Monitoring and Diagnostic Devices March ket, France, Sales (USD Million), 2003?2010 52
Chart 28: Cardiovascular Monitoring and Diagnostic Devices March ket, France, Sales (USD Million), 2010?2017 53
Chart 29: Cardiovascular Monitoring and Diagnostic Devices March ket, Italy, Sales (USD Million), 2003?2010 54
Chart 30: Cardiovascular Monitoring and Diagnostic Devices March ket, Italy, Sales (USD Million), 2010?2017 55
Chart 31: Cardiovascular Monitoring and Diagnostic Devices March ket, Spain, Sales (USD Million), 2003?2010 56
Chart 32: Cardiovascular Monitoring and Diagnostic Devices March ket, Spain, Sales (USD Million), 2010?2017 57
Chart 33: Cardiovascular Monitoring and Diagnostic Devices March ket, Japan, Sales (USD Million), 2003?2010 58
Chart 34: Cardiovascular Monitoring and Diagnostic Devices March ket, Japan, Sales (USD Million), 2010?2017 59
Chart 35: Cardiovascular Monitoring and Diagnostic Devices March ket, China, Sales (USD Million), 2003?2010 60
Chart 36: Cardiovascular Monitoring and Diagnostic Devices March ket, China, Sales (USD Million), 2010?2017 61
Chart 37: Cardiovascular Monitoring and Diagnostic Devices March ket, India, Sales (USD Million), 2003?2010 62
Chart 38: Cardiovascular Monitoring and Diagnostic Devices March ket, India, Sales (USD Million), 2010?2017 63
Chart 39: Cardiovascular Monitoring and Diagnostic Devices March ket, Australia, Sales (USD Million), 2003?2010 64
Chart 40: Cardiovascular Monitoring and Diagnostic Devices March ket, Australia, Sales (USD Million), 2010?2017 65
Chart 41: Cardiovascular Monitoring and Diagnostic Devices March ket, Brazil, Sales (USD Million), 2003?2010 66
Chart 42: Cardiovascular Monitoring and Diagnostic Devices March ket, Brazil, Sales (USD Million), 2010?2017 67
Chart 43: Cardiovascular Monitoring and Diagnostic Devices March ket, Global, Key Market Shares s (%), 2010 68
Chart 44: Cardiovascular Monitoring and Diagnostic Devices, March ket Opportunities (SWOT Analysis) and Risks 69
Chart 45: GE Healthcare, Internal Factors Evaluation 71
Chart 46: Philips Healthcare, Internal Factors Evaluation 73
Chart 47: Fukuda Denshi, Internal Factors Evaluation 74
Chart 48: Nihon Kohden, Internal Factors Evaluation 75
Chart 49: Cardiac Science Corporation, Internal Factors Evaluation 77
Chart 50: Cardiovascular Monitoring and Diagnostic Devices March ket, Acquisitions Deal Analysis - Deal Volume and Value, from 2007 to 2010 93

Companies Mentioned
GE Healthcare
Philips Healthcare
Fukuda Denshi
Nihon Kohden
Cardiac Science Corporation

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Shadi

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers

Coronary Stents Market (Bare Metal Stents, Drug Eluting Stents and Bio-absorbable Stents) - Global Industry Analysis, Size, Share, Pipeline Overview, Growth, Trends and Forecast, 2013 - 2019

Coronary Stents Market (Bare Metal Stents, Drug Eluting Stents and Bio-absorbable Stents) - Global Industry Analysis, Size, Share, Pipeline Overview, Growth, Trends and Forecast, 2013 - 2019

  • $ 4 795
  • Industry report
  • May 2014
  • by Transparency Market Research

This report studies the current as well as future prospects of the coronary stents market globally. The market for coronary stents is categorized into three major segments, namely, bare metal stents (BMS), ...

Cardiovascular Monitoring and Diagnostic Devices Market (ECG, Holter Monitors, Event Monitors, Cardiovascular Diagnostic Catheters, Implantable Loop Recorders, ECG Management Systems) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2

Cardiovascular Monitoring and Diagnostic Devices Market (ECG, Holter Monitors, Event Monitors, Cardiovascular Diagnostic Catheters, Implantable Loop Recorders, ECG Management Systems) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2

  • $ 4 795
  • Industry report
  • May 2014
  • by Transparency Market Research

This report covers the market analysis for various devices used for diagnosing and monitoring of cardiovascular diseases. The stakeholders for this study include the present manufacturers and providers ...

Cardiac Pacemakers - Global Trends, Estimates and Forecasts, 2012-2018

Cardiac Pacemakers - Global Trends, Estimates and Forecasts, 2012-2018

  • $ 4 450
  • Industry report
  • June 2014
  • by Axis Research Mind

Global Market Watch: Global Cardiac Pacemaker sector is projected to reach US$5.7 billion by 2016. The North American segment accounts for nearly 40% (2015) of the global market share while Europe claims ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.